
BlueRock Therapeutics is a clinical-stage engineered cell therapy company pioneering a new generation of cellular medicines.
BlueRock Therapeutics is seeking a Director, Program Management – DA02 to lead the DA02 neurology program towards IND submission and first-in-human clinical studies. The ideal candidate has a strong foundation in scientific, technical, or operational roles within biopharma, coupled with deep experience in program leadership across IND enabling and early clinical development.
BlueRock Therapeutics is a clinical-stage engineered cell therapy company pioneering a new generation of cellular medicines.